These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23077508)

  • 1. Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisation.
    Acevedo R; Pérez O; Zayas C; Pérez JL; Callicó A; Cedré B; García L; Mckee D; Mullen AB; Ferro VA
    PLoS One; 2012; 7(10):e46461. PubMed ID: 23077508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice.
    Acevedo R; Callicó A; del Campo J; González E; Cedré B; González L; Romeu B; Zayas C; Lastre M; Fernández S; Oliva R; García L; Pérez JL; Pérez O
    Methods; 2009 Dec; 49(4):309-15. PubMed ID: 19545630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.
    Campo JD; Zayas C; Romeu B; Acevedo R; González E; Bracho G; Cuello M; Cabrera O; Balboa J; Lastre M
    Methods; 2009 Dec; 49(4):301-8. PubMed ID: 19410000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding cochleate formation: insights into structural development.
    Nagarsekar K; Ashtikar M; Steiniger F; Thamm J; Schacher F; Fahr A
    Soft Matter; 2016 Apr; 12(16):3797-809. PubMed ID: 26997365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence properties of Laurdan in cochleate phases.
    Ramani K; Balasubramanian SV
    Biochim Biophys Acta; 2003 Dec; 1618(1):67-78. PubMed ID: 14643935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocochleates containing N-Octylglicoside extracted Vibrio cholerae antigens elicited high vibriocidal antibodies titers after intragastric immunization in a mice model.
    Tamargo SB; Bui Thanh T; Pérez M; Otero O; Oliva HR; Falero G; Pérez JL; Cedré MB; Okuskhanova E; Thiruvengadam M; Shariati MA; Sierra GVG
    Microb Pathog; 2021 Jul; 156():104902. PubMed ID: 33930421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern.
    Pérez O; Bracho G; Lastre M; Mora N; del Campo J; Gil D; Zayas C; Acevedo R; González D; López JA; Taboada C; Turtle C; Solis RL
    Immunol Cell Biol; 2004 Dec; 82(6):603-10. PubMed ID: 15550118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of the preparation of cochleate suspensions from naturally derived phosphatidylserines.
    Kristensen S; Hassan K; Andersen NS; Steiniger F; Kuntsche J
    Front Med Technol; 2023; 5():1241368. PubMed ID: 37745179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy for determination of an efficient Cochleate particle size.
    Gil D; Bracho G; Zayas C; del Campo J; Acevedo R; Toledo A; Lastre M; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-92-3. PubMed ID: 16823943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvants.
    del Campo J; Lastre M; Bracho G; Rodríguez T; Gil D; Zayas C; Taboada C; Acevedo R; Pérez DR; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-50-1. PubMed ID: 16823924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scale up of proteoliposome derived Cochleate production.
    Zayas C; Bracho G; Lastre M; González D; Gil D; Acevedo R; del Campo J; Taboada C; Solís RL; Barberá R; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-94-5. PubMed ID: 16823944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Mouse Ileal loop Protection against Clinically Isolated Vibrio cholerae Outer Membrane Vesicles as a Vaccine Candidate.
    Sedaghat M; Siadat SD; Shahcheraghi F; Mirabzadeh Ardakani E; Keramati M; Vaziri F; Nojoumi SA
    Arch Razi Inst; 2021 Jan; 75(4):451-461. PubMed ID: 33403840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron microscopy and theoretical modeling of cochleates.
    Nagarsekar K; Ashtikar M; Thamm J; Steiniger F; Schacher F; Fahr A; May S
    Langmuir; 2014 Nov; 30(44):13143-51. PubMed ID: 25318049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Vibrio cholerae with monoclonal antibodies specific for serovar O1 lipopolysaccharide.
    Adams LB; Henk MC; Siebeling RJ
    J Clin Microbiol; 1988 Sep; 26(9):1801-9. PubMed ID: 3053778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine.
    Pérez O; Bracho G; Lastre M; Zayas C; González D; Gil D; del Campo J; Acevedo R; Taboada C; Rodríguez T; Fajardo ME; Sierra G; Campa C; Mora N; Barberá R; Solís RL
    Vaccine; 2006 Apr; 24 Suppl 2():S2-52-3. PubMed ID: 16823925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal and systemic immune responses induced by a single time vaccination strategy in mice.
    González Aznar E; Romeu B; Lastre M; Zayas C; Cuello M; Cabrera O; Valdez Y; Fariñas M; Pérez O
    Can J Microbiol; 2015 Aug; 61(8):531-8. PubMed ID: 26140382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochleate formulations of Amphotericin b designed for oral administration using a naturally occurring phospholipid.
    Lipa-Castro A; Nicolas V; Angelova A; Mekhloufi G; Prost B; Chéron M; Faivre V; Barratt G
    Int J Pharm; 2021 Jun; 603():120688. PubMed ID: 33965540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice.
    Pérez JL; Acevedo R; Callicó A; Fernández Y; Cedré B; Año G; González L; Falero G; Talavera A; Pérez O; García L
    Vaccine; 2009 Jan; 27(2):205-12. PubMed ID: 18996426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoliposome derived cochleate as novel adjuvant.
    Bracho G; Lastre M; del Campo J; Zayas C; González D; Gil D; Acevedo R; Taboada C; Solís RL; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-30-1. PubMed ID: 16823914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.